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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S90Purpose: Lubricin (aka. PG4, superﬁcial zone protein) is secreted by
synovial ﬁbroblast and chondrocyte of superﬁcial layer of articular carti-
lage, where it maintains a lubricated and friction-less surface. We specu-
lated that that degradation lubricin by neutrophil elastase whose
expression is up-regulated following inﬂammatory insults and the release
of these fragments into the synovial cavity might be an early biomarker of
joint diseases. We therefore set-out to develop an ELISA measuring
protease derived fragments of lubricin.
Methods: Human cartilage and synovial membrane were in vitro digested
by a variety of MMPs, aggrecanase, cysteine proteinase and serine
proteinase respectively, including MMP2, MMP12, MMP13, ADAMTS4,
ADAMTS5, Cathepsin B and Neutrophil Elastase. The proteolysis products
were analyzed by mass spectrometry and evaluated using the Mascot
database. A cleavage fragment (neoepitope) of lubricin was identiﬁed. A
peptidewas generated, which conjugated to KLH- and used as immunogen.
Six eight-week old Balb/C mice were immunized sequentially and the
immuno-reactivity towards the lubricin neoepitopewas tested after 3rd, 4th
and 5th immunization. Mice with best reactivity were selected and spleens
were isolated and fused with SP2/O cells. The hybridomas were subse-
quently cloned by classic limiting dilution method, and subclones were
produced. The best monoclonal antibody was selected based on following
criteria: speciﬁcity towards neoepitope using a speciﬁc peptide (positive
control), elongated peptide (negative control) and nonsense peptide
(negative control). Furthermore, the Mabs were tested for reactivity in
native samples, such as serum, urine, synovial ﬂuid and culture superna-
tants. A competition ELISA was developed using the best Mab with
following procedure: a 96-well streptavidin-coated plate was coated with
1ng/ml Biotin labeled lubricin neoepitope for 30 min at 20C, at 300 rpm.
The plate was then washed 5 times with standard wash solution. Standard
and samples were added 20ul/well, followed by the addition of 100ul/well
peroxidase labeled antibody and incubated onvernight (201 h) at 4C, at
300 rpm. After that, the wells were washed 5 times and incubated with
100ul/well TMB at 20C, at 300 rpm for 15 min. Then 100ul/well stop
solution was added and the colorimetric reaction was measured at 450nm
with reference at 650nm. The ELISAwas used to characterize the release of
the fragments from human cartilage explants.
Likewise, synovial ﬂuid samples from OA patients were measured (n¼15).
Results: A speciﬁc lubricin neoepitope with C-terminal cleavage site
generated by Neutrophil Elastase was identiﬁed by mass spectrometry.
Blasting results showed that it was speciﬁc for human lubricin. All mice had
strong immunization response to the neoepitope linked KLH-immunogen.
After serial subcloning, one antibody producing clone, Mab-13H1, with IgG
[[Unsupported Character - L]] isotype was obtained and characterized. It
had speciﬁc response to the speciﬁc peptide, but not toward the elongated
peptide. Thus the Mab-13H1 was speciﬁc for the cleavage site. The
competitiveELISA showedgood technical performance:1)measuring range
from 0.27ng/ml to 200ng/ml; 2) intra- and inter-assay CVs: 10% and 15%; 3)
Dilution recovery of human serum samples: 82.8%-112%; 4) interference:
blocked by adding liquid-II. The neoepitope was found in synovial ﬂuid of
patients with range from 1,16ng/ml to 23,042ng/ml (unadjusted values).
Conclusion: We identiﬁed and developed a new competitive ELISA for
measuring of lubricin neoepitope primarily from synovial membrane. We
found measurable amounts in synovial ﬂuid of RA patients, indicating that
this could be a novel biomarker of early cartilage loss.
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TWO NOVEL DIAGNOSTIC BIOMARKERS OF CARTILAGE DEGRADATION
AND CONNECTIVE TISSUE INFLAMMATION ARE PREDICTIVE OF
RADIOGRAPHIC DISEASE PROGRESSION
A.-C. Bay-Jensen 1, S. Wichuk 2, I. Byrjalsen 1, M.A. Karsdal 1,
W.P. Maksymowych 2. 1Nordic BioSci. A/S, Herlev, DENMARK; 2Div. of
Rheumatology, University of Alberta, AB, CANADAPredictive value for radiographic progression of serum C2M and C3M
High C2M (n¼94) High C3M (n¼
Positive predictive value 0.44 (0.27 - 0.62) 0.59 (0.41 - 0.7
Negative predictive value 0.70 (0.57 - 0.81) 0.57 (0.43 - 0.6Purpose: Cartilage degradation and inﬂammation of connective tissue are
key events in inﬂammatory and non-inﬂammaory arthropathies, such as
osteoarthritis (OA), rheumatoid arthritis (RA) and ankylosing spondylitis
(AS). Presently there are no prognostic tools available for measuring these
tissue related processes, which are often the target of intervention.
Inﬂammation induces an increase in collagenases. An elevated level of
collagenases will lead to increased degradation of the disease affected
tissues, e.g. cartilage and synovial tissue. Type II collagen is the primary
protein component of cartilage and type III collagen is one of the major
proteins of many connective tissues (e.g. synovial membrane); thus they
are obvious targets for the action of collagenases. The objective of the
study was to investigate whether those fragments could be used as
predictive biomarkers of radiographic disease progression.
Method: Serum samples were collected from patient suffering from AS
(n¼124) at baseline and 2-3 month treatment follow-up. Standard AS
clinical outcome scores were collected: BASDAI (health questionnaire) and
mSASSS (radiographic scoring). Progressors were deﬁned as having new
vertebra syndesmophytes over a two year period. Serum levels of type II
collagen degradation was measured by the C2M competitive ELISA, and
type III collagen degradation by the C3M ELISA. Serum hsCRP was likewise
measured. Logistic regression and CART were used to analyze the prog-
nostic value of the markers individually or in combination.
Results: Both cartilage and connective tissue degradation fragments, C2M
and C3M, were signiﬁcantly elevated in AS patient serum samples
compared to healthy controls (p<0.0001). The area under the curves of
C2M and C3M, respectively, were 70% and 81% for AS. C3M correlated
signiﬁcantly with AS score BASDAI and mSASSS (p<0.01). C2M did not
show the same correlations. A combination of the two markers could
predict 80% of those who was deﬁned as progressors, with a negative
predictive value of 61%.
Conclusion:Present study is theﬁrst to showthat the twonovelbiomarkers
of cartilage andconnective tissuedegradation addadditional information to
the understanding of the diagnosis and progression of arthropathies. No
other clinical score or biomarker possesses these properties.
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GLA RICH PROTEIN (GRP) IS ASSOCIATED TO OSTEOARTHRITIS BEING
HIGHLY ACCUMULATED IN THE JOINT TISSUES AND SYNOVIAL FLUID
S.I. Cavaco 1, C.B. Viegas 1,2, R. Marta 1, R. Acácio 3, J. Silva 3, J.L. Morera 4,
A. Teixeira 4, E. Smit 5, M. Herfs 5, C. Vermeer 5, D.C. Simes 1,2. 1CCMAR,
Algarve Univ., Faro, PORTUGAL; 2GenoGla Diagnostics, Faro, PORTUGAL;
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4 Faro Hosp., Dept. of Anatomical Pathology, Faro, PORTUGAL; 5VitaK,
Maastricht Univ., Maastricht, NETHERLANDS
Purpose: The newly discovered Gla-rich protein (GRP) is a vitamin K-
dependent protein with high calcium-binding ability through its Gla
residues. It was recently shown to be highly expressed and accumulated in
rat cartilage and bone, and was suggested to be an important new player in
the complexity of phenotypes involving connective tissue mineralization.
With this work we aim to unveil the relationship between GRP and the
molecular mechanisms involved in cartilage degradation and calciﬁcation
associated with osteoarthritis (OA).
Methods: To investigate a possible involvement of GRP in OA processes we
have analyzed samples of synovial membrane, cartilage, subchondral bone
and synovial ﬂuid, collected from OA patients at the time of total knee
arthroplasty. Western blot and immunohistochemistry (IHC) techniques
were performed using polyclonal antibodies against total GRP (CTerm-
GRP) and the carboxylated form of GRP (anti-cGRP). Protein extracts from
cartilage and synovial ﬂuid were also analyzed using 2-D electrophoresis
and GRP was detected by Western blot. The presence of the four GRP
isoforms previously described in mouse was analyzed in human joint
tissues using speciﬁc primers.94) High hsCRP (n¼87) High C2M & high C3M (n¼33)
5) 0.33 (0.17 - 0.53) 0.80 (0.52 - 0.96)
9) 0.74 (0.60 - 0.84) 0.61 (0.36 - 0.83)
